Post-transcriptional modification of pro-BNP in heart failure: Is glycosylation and circulating furin key for cardiovascular homeostasis?

European Heart Journal

Volumn 35, Issue 43, 2014, Pages 3001-3003

  Ichiki, Tomoko ^a   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CORIN; FURIN; SERINE PROTEINASE; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

EDITORIAL; GLYCOSYLATION; HEART FAILURE; HUMAN; PROTEIN METABOLISM; PROTEIN PROCESSING; BIOSYNTHESIS; BLOOD; FEMALE; MALE;

FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 84911863918     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu381     Document Type: Editorial

References (12)

1. Goetze JP, Christoffersen C, PerkoM, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiacBNPexpression associated with myocardial ischemia. Faseb J 2003; 17(9):1105-1107.
2. Ichiki T, Huntley BK, Burnett JC Jr. BNP molecular forms and processing by the cardiac serine protease corin. Advances in Clinical Chemistry 2013;61:1-31.
3. Dong N, Chen S, WangW, Zhou Y, Wu Q. Corin in clinical laboratory diagnostics. Clin Chim Acta 2012;413(3-4):378-383.
4. Nakayama K. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 1997;327 (Pt 3): 625-635.
5. Ichiki T, Boerrigter G, Huntley BK, Sangaralingham SJ, McKie PM, Harty GJ, Harders GE, Burnett JC Jr. Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis. Am J Physiol Regul Integr Comp Physiol 2013;304(2):R102-R109.
6. Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC Jr., Ikeda Y. Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes. Clin Chemi. 2011;57(6):864-873.
7. Peng J, Jiang J, Wang W, Qi X, Sun XL, Wu Q. Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes. Biochem Biophys Res Commun 2011;411(3):593-598.
8. Nishikimi T, Ikeda M, Takeda Y, Ishimitsu T, Shibasaki I, Fukuda H, Kinoshita H, NakagawaY, Kuwahara K, Nakao K. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure. Heart 2012;98(2):152-161.
9. Vodovar N, Seronde MF, Laribi S, Gayat E, Lassus J, Boukef R, Nourira S, Manivet P, Samuel JL, Logeart D, Ishihara S, Solal AC, Januzzi JL, Richards AM, Launay JM, Mabazaa A. Post-translational Modifications Enhance NT-proBNP and BNP Production in Acute Decompensated Heart Failure. Eur Heart J 2014; doi:10.1093/eurheartj/ehu314.
10. Lisy O, RedfieldMM, Schirger JA, Burnett JCJr. AtrialBNPendocrine function during chronic unloading of the normal canine heart. Am J Physiol Regul Integr Comp Physiol 2005;288(1):R158-R162.
11. Costello-Boerrigter L, Lapp H, Boerrigter G, Lerman A, Bufe A, Macheret F, Heublein D, Larue C, Burnett J. Secretion of Prohormone of B-Type Natriuretic Peptide, proBNP1-108, Is Increased in Heart Failure. JACC: Heart Failure 2013;1(3): 207-212.
12. Chen HH, Glockner JF, Schirger JA, Cataliotti A, Redfield MM, Burnett JC Jr. Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide. J Am Col Cardiol. 2012;60(22):2305-2312.